Tuesday, July 7, 2020

COVID-19 CLINICAL TRIAL

Submitted by: Eduardo Nunez

This article, in conjunction with the retraction of two major articles that suggested HCQ didn't work(they used faulty data) now puts HCQ back on the front-burner" as a viable intervention with more than just "anecdotal data"-this is observational data from a clinical trial.


For the record, my regimen of choice that I offer my suspected COVID-19 patients who refuse to "just wait for a vaccine", always contains Ivermectin. I also mix in two or more various other Meds that I feel may work better or safer for a particular patient demographic with confirmed or early suspected COVID 19. It may contain Hydroxychloroquine, Baloxavir or Atovaquone/Proguanil ,or Colchicine, or Azithromycin, along with Nitazoxanide, Famotidine, and Dexamethasone.
Even Fluoxetine(Prozac) has shown the ability to inhibit COVID 19 in vitro, by interfering early in the sequence of gene -expression of the Coronavirus RNA(a property that has nothing to do with it's inhibition of selective serotonin re-uptake, by the way!) Be that as it may, this one's especially dedicated to my pal Sporkie Devine -- International Journal of Infectious Diseases

No comments:

Post a Comment